Tuberculosis drug resistance and outcomes among tuberculosis inpatients in Lilongwe, Malawi

Malawi Medical Journal

Volumn 24, Issue 2, 2012, Pages 21-24

  Vorkas, Charles ^a   Kayira, Dumbani ^b   van der Horst, Charles ^a   Hoffman, Irving ^a   Hosseinipour, Mina ^a,b   Kanyemba, Creto ^b   Nguluwe, Nelson ^a,b   Chikaonda, Tarsizio ^b   Kalikhoka, Maximina ^b   Kalaundi, Doreen ^b   Namarika, Dan ^b   Gilligan, Peter ^b   Krysiak, Robert ^b  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^b UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CULTURE MEDIUM; DRUG EFFECT; FEMALE; GENETICS; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MALAWI; MALE; METHODOLOGY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MICROSCOPY; MIDDLE AGED; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; SPUTUM; STATISTICS; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; CULTURE MEDIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HIV INFECTIONS; HUMANS; INPATIENTS; MALAWI; MALE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OBSERVATIONAL STUDY AS TOPIC; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RNA, VIRAL; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84867021912     PISSN: 19957262     EISSN: 19957270     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Brust JC, Ghandi NR, Carrara H, et al. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003. Int J Tuberc Lung Dis 2010; 13:413-9
2. WHO. Tuberculosis country profile: Malawi. Accessed on July 16, 2011. https://extranet.who.int/sree/Reports?op=Replet&name=/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=MW&outtype=html
3. WHO. Multidrug and extensively drug-resistant tuberculosis (X/MDR-TB): 2010 Global Report on Surveillance and Response. 2010
4. WHO. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). Geneva: World Health Organisation.2008
5. Chien HP, Yu MC, Wu MH, et al. Comparison of the BACTEC MGIT 960 withLöwenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Int J Tuberc Lung Dis 2000; 4: 866-870
6. Idigoras P, Beristain X, Iturzaeta A, et al. Comparison of the automated nonradiometric Bactec MGIT 960 System with Löwenstein-Jensen, Colletsos, and Middlebrook 7H11 solid media for recovery of mycobacteria. Eur J Clin Microbiol Infect Dis 2000; 19: 350-354
7. Lu D, Heeren B, Dunne WM. Comparison of the automated Mycobacteria Growth Indicator Tube System (BACTEC 960/MGIT) with Löwenstein-Jensen Medium for recovery of mycobacteria from clinical specimens. Am J Clin Pathol 2002; 118: 542-545
8. Mueller DH, Mwenge L, Muyoyeta M, et al. Costs and cost-effectiveness of tuberculosis cultures using solid and liquid media in a developing country. Int J Tuberc Lung Dis 2008; 12:1196-1202
9. Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis ofmultidrug-resistant tuberculosis: A meta-analysis. Eur Resp J 2008; 32:1165-1174
10. Harries AD, Kamenya A, Namarika D, et al. Delays in diagnosis and treatment of smear-positive tuberculosis and incidence of tuberculosis in hospital nurses in Blantyre, Malawi. Trans R Soc Trop Med Hyg 1997; 91:15-7
11. Couto I, Machado D, Viveiros M, et al. Identification of nontuberculous mycobacteria in clinical samples using molecular methods: A 3-year study. Clin Microbiol Infect 2010; 16:1161-1164
12. Kiet VS, Lan NT, An DD, et al. Evaluation of MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis. J Clin Microbiol 2010; 48:2934-2939
13. Gordin FM, Sullam PM, Shafran SD, et al. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex. Clin Infect Dis. May 1999;28(5):1080-5
14. Mallard K, McNerney, Crampin AC, et al. Molecular 459 Detection of Mixed nfections of Mycobacterium tuberculosis Strains in Sputum Samples from Patients in Karonga District, Malawi. J Clin Microbiology 2010; 48: 4512-4518
15. Van Rie A, Page-Shipp L, Lesley S, et al. Xpert® 463 MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: HYpe or hope? Expert Rev Mol Diagn 2010; 10:937-946
16. Boehme CC, Nabeta P, Hilleman, et al. Rapid Molecular Detection of Tuberculosis and Rifampin Resistance. N Engl J Med 2010; 363:1005-1015